LARGE CELL NEUROENDOCRINE CARCINOMA
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack shows promise for rare bladder and kidney cancers
Disease control Recruiting nowThis study tests a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in people with rare genitourinary cancers that have spread. The goal is to see if this mix can shrink tumors or stop them from growing. About 314 adults with these rare cancers will take part. T…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New radiation therapy targets tough lung cancers in early trial
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells with a protein called DLL3, found in small cell lung cancer and similar tumors. About 138 adults with advanced cancer that has not responded to standard treatments will receive the drug to check safety, …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 17, 2026 00:49 UTC